Group One Trading
RLMD icon

Group One Trading’s Relmada Therapeutics RLMD Stock Holding History

Group One Trading’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.6K Buy
+5,400
New +$25.5K ﹤0.01% 5483
2025
Q1 		– Sell
-22,300
Closed -$11.6K – 8267
2024
Q4 		$11.6K Buy
22,300
+10,800
+94% +$26.3K ﹤0.01% 6026
2024
Q3 		$37.3K Sell
11,500
-6,000
-34% -$19.4K ﹤0.01% 4839
2024
Q2 		$52.5K Sell
17,500
-37,000
-68% -$134K ﹤0.01% 4499
2024
Q1 		$253K Sell
54,500
-129,700
-70% -$625K ﹤0.01% 3351
2023
Q4 		$763K Buy
184,200
+3,900
+2% +$11.5K ﹤0.01% 2710
2023
Q3 		$541K Sell
180,300
-200,200
-53% -$595K ﹤0.01% 2829
2023
Q2 		$936K Buy
380,500
+374,000
+5,754% +$1.03M ﹤0.01% 2419
2023
Q1 		$14.7K Sell
6,500
-104,400
-94% -$360K ﹤0.01% 5717
2022
Q4 		$387K Sell
110,900
-328,500
-75% -$2.89M ﹤0.01% 3276
2022
Q3 		$16.3M Buy
439,400
+410,300
+1,410% +$11.4M 0.03% 487
2022
Q2 		$553K Buy
29,100
+26,700
+1,113% +$582K ﹤0.01% 3321
2022
Q1 		$65K Buy
2,400
+2,000
+500% +$41.4K ﹤0.01% 5896
2021
Q4 		$9K Sell
400
-900
-69% -$20K ﹤0.01% 7415
2021
Q3 		$34K Buy
+1,300
New +$34.8K ﹤0.01% 6835
2020
Q2 		– Sell
-100
Closed -$3K – 6114
2020
Q1 		$3K Hold
100
– – ﹤0.01% 4904
2019
Q4 		$4K Buy
+100
New +$3.04K ﹤0.01% 4800

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Group One Trading's RLMD Position: Q1 2026 in Review

Group One Trading opened a new position in Relmada Therapeutics (RLMD) in Q1 2026: 14,350 shares worth $99.9K. The stake represents ﹤0.01% of the portfolio and ranks #4726 among its holdings. This is a return to the name: Group One Trading previously reported a position in RLMD as recently as Q2 2025.

Group One Trading first reported a position in RLMD in Q1 2021 and has held it in 16 quarters since. The position peaked at $857K in Q1 2024. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Group One Trading held 14,350 shares of Relmada Therapeutics worth $99.9K as of Q1 2026.
  • Relmada Therapeutics was a new Group One Trading position in Q1 2026.
  • Relmada Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4726 holding.
  • Group One Trading first reported a position in Relmada Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Group One Trading's Relmada Therapeutics position peaked at $857K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.